DataVault AI and Wellgistics Health Announce Plans to Expand Partnership to Include Healthcare Delivery Intellectual Property for Healthcare as a Service (HaaS) Blockchain-enabled Smart Contracts
Rhea-AI Summary
Datavault AI (NASDAQ:DVLT) and Wellgistics Health plan to expand a blockchain smart-contracts partnership to support Healthcare as a Service (HaaS) integration.
The deal adds Datavault AI intellectual property to enable tokenized patient data, pharmacy fulfillment via Wellgistics Pharmacy, telemedicine links, and an updated iOS app for patient adoption.
Positive
- Adds Datavault AI IP to enable HaaS tokenization
- Wellgistics Pharmacy positioned as primary U.S. distribution channel
- Partnership leverages NFL Alumni Health for patient outreach
Negative
- No quantified near-term revenue or timelines disclosed
- Integration scope spans many partners, raising execution complexity
- Reliance on app adoption and network participation for material scale
Key Figures
Market Reality Check
Peers on Argus
DVLT was down 3.87% pre-news. Peers were mixed: INTZ (-7.19%), CSAI (-12.17%), AUID (-5.44%) weaker, while USIO gained (+3.08%) and VRAR was flat, suggesting stock-specific rather than broad sector follow-through.
Previous Partnership,AI Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 07 | Retail tech partnership | Positive | -16.1% | Riflessi collaboration to deploy DVHOLO and ADIO in luxury retail. |
| Dec 22 | Media/crypto tie-in | Positive | -1.8% | Dream Bowl broadcast partnership plus meme coin claim process details. |
| Nov 06 | Entertainment partnership | Positive | -15.0% | Rodney’s Comedy Club deal using VerifyU, Joke Token and ADIO. |
| Oct 20 | RWA exchange launch | Positive | +35.2% | Max International AG partnership for Swiss Digital RWA Exchange. |
| Sep 29 | IBM expansion | Positive | +5.5% | IBM commits 20,000 engineering hours and AI/quantum support. |
Partnership/AI announcements have produced mixed reactions, with more downside than upside in prior events despite generally positive strategic framing.
Over recent months, Datavault AI has paired rapid revenue growth with a series of strategic deals. On Feb 17, 2026 it raised FY-25 revenue estimates to $38–$40M and reaffirmed $200M for FY-26, yet the stock fell 5.53%. Multiple AI and tokenization partnerships across entertainment, sports, and financial inclusion from Sep 2025 onward show a pattern of heavy newsflow. Today’s healthcare-focused partnership extension fits this strategy of applying the platform into large adjacent markets.
Historical Comparison
In the past year DVLT issued 5 partnership/AI releases with an average move of 1.55%, showing that similar announcements have generated modest and often inconsistent price reactions.
Partnerships have expanded Datavault AI’s footprint from entertainment and retail into institutional tokenization and now healthcare, applying its tokenization and smart-contract IP across increasingly large end markets.
Regulatory & Risk Context
Datavault AI has an effective Form S-3 shelf filed on Oct 17, 2025, registering up to 5,000,000 resale shares for existing holders. The company receives no proceeds from these sales but faces potential overhang from registered stock. The shelf has been tapped via at least two 424B5 prospectus supplements, indicating active use of its registration framework.
Market Pulse Summary
This announcement expands Datavault AI’s smart-contract and tokenization platform into healthcare via Wellgistics’ HaaS model, tying into markets such as blockchain in healthcare at $11B in 2024 and diagnostics at $1.1T. Historically, similar partnership/AI news led to mixed price moves, despite large stated TAMs. Investors may monitor execution milestones, regulatory integration, and any further use of the existing Form S-3 registration when assessing long-term impact.
Key Terms
smart contracts technical
telehealth medical
wearables medical
tokenization technical
digital twins technical
quantum computing technical
information data exchange technical
AI-generated analysis. Not financial advice.
Ongoing PharmacyChain® technology build-out already involves key technology components necessary to enable Healthcare as a Service (HaaS) smart contracts
Datavault AI partner programming capabilities included to speed market entry
Wellgistics' recently announced NFL Alumni Health partnership provides trusted marketing capability to help drive market awareness and adoption
Wellgistics Pharmacy's online prescription fulfillment capability set to become primary distribution channel for prescription drugs and OTC health products
Wellgistics Pharmacy Network participants to enable 'hub and spoke' model for in-person healthcare touchpoints for patients and local providers via referral network
Wellgistics plans to update its current iOS app as the vehicle to enable adoption
PHILADELPHIA, PA AND TAMPA, FL / ACCESS Newswire / February 23, 2026 / Datavault AI Inc. (NASDAQ:DVLT)("Datavault AI"), a provider of data monetization, credentialing, digital engagement, and real-world asset tokenization technologies, and Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics"), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence ('AI') platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™, today announced plans to expand their existing blockchain-enabled smart contracts partnership initially focused on digitizing tracking of prescription drugs from script to fulfillment. The companies intend to add additional Datavault AI intellectual property that will enable Wellgistics' emerging Healthcare as a Service ('HaaS') business model that will include data integration from hospitals, clinics, diagnostics labs, mental health AI tools, wearables and insurance companies in order to deliver a comprehensive healthcare solution designed to improve patient outcomes while reducing total cost of care.
"Our recently announced partnership with NFL Alumni Health allows us to have confidence that we have a trusted partner capable of reaching and motivating patients to take greater control over their healthcare with HaaS," said Prashant Patel, RPh, President & Interim-CEO of Wellgistics Health. "With the emergence of telehealth as fixture in the healthcare system, and all key constituents within healthcare increasing adopting cloud-based solutions to help integrate data transfer, it makes perfect sense to target a comprehensive app-based solution that integrates various' provider data outputs for patients to take control of their healthcare. Datavault AI's unique smart contracts intellectual property positions us to have a protected first mover advantage for our proprietary app through which patients will be able to securely consolide all of the key HaaS data needed in order to train our AI models with a view towards improving patients outcomes with a lower total cost of care."
Wellgistics intends to deploy a 'hub and spoke' prescription drug delivery model relying primarily on its own online Wellgistics Pharmacy in the United States to dispense prescription drug and OTC products to patients, while facilitating patient engagement with local independent pharmacies within the Wellgistics Pharmacy Network for urgent fulfilment and for more complex healthcare interactions, including a local referral network for non-prescription drug-related healthcare services. The Company is leveraging its partnership with Tollo Health to enable telemedicine visits initially targeting the GLP-1 and Long COVID markets, as well as a patient engagement tool via a stealth mental health AI startup in which Wellgistics recently made a strategic investment . Wellgistics intends to continue to expand its ecosystem to include hospitals, clinics, diagnostic labs, as well as other healthcare and wellness service providers to make available the best solution for patients. Wellgistics plans to update its current iOS app as the patient adoption mechanism.
"Datavault AI is focused on the creation of shareholder value with and for our partners through strategic field of use licensing. We believe our license and royalty agreement with Wellgistic allows us together to solve for pharmaceutical logistics issues, using blockchain and AI, that have plagued the healthcare industry for far too long," said Nathaniel Bradley, President & CEO of Datavault AI. "We intend to work very closely with Wellgistics' management, while making available our patented solutions that will have Wellgistics prepared for the leap to quantum computing and as an immutable future in this all important market of healthcare."
The global blockchain in healthcare market currently stands at
These healthcare markets are expected to be significantly disrupted by technology adoption in the coming years as the need for secure data transfer and AI analysis necessitates access to blockchain-enabled solutions that address the pending quantum computing paradigm shift. Wellgistics and Datavault AI believe they are well positioned to take advantage of these market shifts.
"We are very excited with the direction of our Datavault AI partnership given their unique intellectual property as it relates to smart contracts, digital twins and data valuation in healthcare," said Srini Kalla, Chief Technology Officer at Wellgistics. "Having previously served in senior roles at OptumRx (NYSE: UNH) and Elevance Health (NYSE: ELV), I am excited to be here at Wellgistics as we begin the smart contracts revolution in healthcare with a proprietary intellectual property position."
DataVault AI's industry-leading platform, including its patented Information Data Exchange® (IDE) and expertise in securely attaching physical assets to immutable blockchain metadata, provide the foundational intellectual property that enables this tokenization. By leveraging DataVault AI's robust, regulatory-compliant technology, Wellgistics can create tokenized digital representations of healthcare-related elements - from patient profiles to diagnostic lab results to prescription fulfillment - facilitating seamless smart contract execution, real-time data integrity, reduced intermediaries, and new avenues for efficient, trustless, quantum-proof healthcare transactions.
About Wellgistics Health, Inc.
Wellgistics Health (NASDAQ: WGRX) is a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™ to optimize the prescription drug dispending journey. Its integrated platform connects 6,500+ pharmacies (the "Wellgistics Pharmacy Network") and 200+ manufacturers, offering wholesale distribution, digital prescription routing, direct-to-patient delivery, and AI-powered hub services such as eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment as needed to optimize patient access. Wellgistics provides end-to-end solutions designed to restore access, transparency, and trust in the U.S. prescription drug market for independent pharmacies.
For more information, visit www.wellgisticshealth.com.
About Datavault AI
Datavault AI™ (NASDAQ:DVLT) is leading the way in AI driven data experiences, valuation and monetization of assets in the Web 3.0 environment. Datavault AI is an IBM Platinum Partner. The Company's cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Science and Data Science Divisions. Datavault AI's Acoustic Science Division features WiSA®, ADIO® and Sumerian ® patented technologies and industry-first foundational spatial and multichannel wireless HD sound transmission technologies with IP covering audio timing, synchronization and multi-channel interference cancellation. The Data Science Division leverages the power of Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation and secure monetization. Datavault AI's cloud-based platform provides comprehensive solutions serving multiple industries, including HPC software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy and more. The Information Data Exchange ® (IDE) enables Digital Twins, licensing of name, image and likeness (NIL) by securely attaching physical real-world objects to immutable metadata objects, fostering responsible AI with integrity. Datavault AI's technology suite is completely customizable and offers AI and Machine Learning (ML) automation, third-party integration, detailed analytics and data, marketing automation and advertising monitoring. The Company is headquartered in Philadelphia, PA. Learn more about Datavault AI at www.dvlt.ai.
Forward-Looking Statements
This press release contains "forward-looking statements" (within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and other securities laws) about Datavault AI Inc. ("Datavault AI," the "Company," "us," "our," or "we") and our industry that involve risks and uncertainties. In some cases, you can identify forward-looking statements because they contain words, such as "may," "might," "will," "shall," "should," "expects," "plans," "anticipates," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," "goal," "objective," "seeks," "likely" or "continue" or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. The absence of these words does not mean that a statement is not forward-looking. Such forward-looking statements, including, but not limited to, statements regarding future events, the timing, scope and expected benefits of Datavault AI's audience engagement activities and outreach, and the anticipated benefits of Datavault AI's commercial partnerships and/or collaborations, including, without limitation, with Sports Illustrated, are necessarily based upon estimates and assumptions that, while considered reasonable by the Company and its management, are inherently uncertain. Readers are cautioned not to place undue reliance on these and other forward-looking statements contained herein.
Actual results may differ materially from those indicated by these forward-looking statements as a result of various risks and uncertainties including, but not limited to, the following: risks related to the ability of Datavault AI to successfully implement its commercial partnerships, collaborations and/or strategies; changes in market demand for Datavault AI's services and products; changes in economic, market, or regulatory conditions; risks relating to evolving regulatory frameworks applicable to tokenized assets; risks associated with technological development and integration; and other risks and uncertainties as more fully described in Datavault AI's filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2024 and other filings that Datavault AI makes from time to time with the SEC, which are available on the SEC's website at www.sec.gov, and could cause actual results to vary from expectations.
The forward-looking statements made in this press release relate only to events as of the date on which the statements are made. Datavault AI undertakes no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law. Datavault AI may not actually achieve the plans, intentions or expectations disclosed in its forward-looking statements, and you should not place undue reliance on such forward-looking statements. Datavault AI's forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments it may make.
Trademarks, Trade Names, Service Marks and Copyrights
We own or have rights to use various trademarks, tradenames, service marks and copyrights, which are protected under applicable intellectual property laws. This press release also contains trademarks, tradenames, service marks and copyrights of other companies, which are, to our knowledge, the property of their respective owners. Solely for convenience, certain trademarks, tradenames, service marks and copyrights referred to in this press release may appear without the ©, ®, and symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensors to these trademarks, tradenames, service marks and copyrights. We do not intend our use or display of other parties' trademarks, tradenames, service marks or copyrights to imply, and such use or display should not be construed to imply a relationship with, or endorsement or sponsorship of us by, these other parties.
Media Contact:
Wellgistics Media & Investor Contact
Media:
media@wellgisticshealth.com
Investor Relations:
IR@wellgisticshealth.com
SOURCE: Wellgistics Health, Inc.
View the original press release on ACCESS Newswire
FAQ
What will Datavault AI and Wellgistics expand in their February 23, 2026 partnership (DVLT)?
How does the expanded DVLT partnership affect Wellgistics Pharmacy distribution plans?
What market opportunity sizes are cited in the Datavault AI and Wellgistics announcement for DVLT?
Will the DVLT partnership include telemedicine and mental health tools in HaaS?
What technology from Datavault AI supports the HaaS expansion for DVLT shareholders?
How will patient adoption be enabled under the DVLT and Wellgistics expanded partnership?
